BIOGEN IDEC $232.62

down -0.45


23/5/2013 04:23 PM  |  NASDAQ : BIIB  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
5/26/2011 LEAMING NANCY Director -28,544 $92.98 -67.97%
5/26/2011 LEAMING NANCY Director -4,631 $93.50 -34.43%
5/26/2011 PANGIA ROBERT W Director 10,000 $68.15 71.02%
5/26/2011 PANGIA ROBERT W Director 5,000 $34.34 20.76%
5/26/2011 PANGIA ROBERT W Director -12,800 $93.04 -44.02%
5/26/2011 PANGIA ROBERT W Director -2,200 $93.50 -13.51%
5/25/2011 Posner Brian S Director 20,000 $71.38 127.35%
5/25/2011 Posner Brian S Director -12,805 $93.74 -35.86%
5/25/2011 Posner Brian S Director -13,170 $94.43 -57.51%
5/25/2011 Posner Brian S Director 5,975 $53.43 61.41%
5/6/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -967 $96.13 -11.09%
5/4/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -215 $96.03 -2.41%
5/3/2011 Cox John EVP Pharmaceutical Oper & Tech -765 $97.99 -7.39%
5/3/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -450 $97.99 -4.79%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -2,876 $97.54 -8.03%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -2,816 $97.52 -9.46%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -3,177 $96.90 -9.64%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -5,100 $97.02 -18.91%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -2,900 $97.52 -13.26%
5/2/2011 ALEXANDER SUSAN H EVP, General Counsel -4,124 $96.97 -10.32%
5/1/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -101 $97.65 -1.06%
4/28/2011 Clancy Paul J Executive VP and CFO -4,061 $98.83 -7.82%
4/28/2011 Clancy Paul J Executive VP and CFO -700 $99.27 -1.46%
4/28/2011 Clancy Paul J Executive VP and CFO -1,300 $99.28 -2.68%
4/28/2011 Clancy Paul J Executive VP and CFO 10,005 $37.45 21.20%
4/28/2011 Clancy Paul J Executive VP and CFO -8,705 $98.85 -15.22%
4/28/2011 Clancy Paul J Executive VP and CFO 4,761 $49.03 10.09%
4/28/2011 Clancy Paul J Executive VP and CFO -1,263 $98.83 -2.74%
4/28/2011 Clancy Paul J Executive VP and CFO -291 $99.36 -0.63%
4/28/2011 Clancy Paul J Executive VP and CFO -874 $98.75 -1.85%
4/28/2011 Clancy Paul J Executive VP and CFO -485 $99.12 -1.13%
4/28/2011 Clancy Paul J Executive VP and CFO -1,657 $98.86 -3.73%
4/28/2011 Clancy Paul J Executive VP and CFO -290 $99.36 -0.65%
4/28/2011 Clancy Paul J Executive VP and CFO -90 $99.69 -0.21%
4/21/2011 Cox John EVP Pharmaceutical Oper & Tech -4,350 $100.00 -29.59%
4/21/2011 Cox John EVP Pharmaceutical Oper & Tech 4,350 $72.87 42.02%
4/20/2011 SCHENK LYNN Director 5,700 $59.17 19.29%
4/20/2011 SCHENK LYNN Director -27,275 $85.00 -77.36%
4/20/2011 SCHENK LYNN Director 5,950 $52.22 25.21%
4/20/2011 SCHENK LYNN Director 3,125 $46.99 15.26%
4/20/2011 SCHENK LYNN Director 12,500 $66.29 156.64%
4/20/2011 SCHENK LYNN Director -10,000 $85.81 -55.62%
4/20/2011 SCHENK LYNN Director 10,000 $68.15 125.31%
4/13/2011 Cox John EVP Pharmaceutical Oper & Tech 3,900 $67.57 37.67%
4/13/2011 Cox John EVP Pharmaceutical Oper & Tech 7,400 $49.31 51.92%
4/13/2011 Cox John EVP Pharmaceutical Oper & Tech 7,587 $49.65 19.45%
4/13/2011 Cox John EVP Pharmaceutical Oper & Tech 17,347 $60.56 80.11%
4/13/2011 Cox John EVP Pharmaceutical Oper & Tech -36,234 $80.00 -77.78%
4/11/2011 Cox John EVP Pharmaceutical Oper & Tech -6,900 $78.00 -39.99%
4/11/2011 Cox John EVP Pharmaceutical Oper & Tech 6,900 $47.92 66.65%
3/31/2011 Cox John EVP Pharmaceutical Oper & Tech 2,840 $43.50 28.93%
3/31/2011 Cox John EVP Pharmaceutical Oper & Tech -2,840 $73.00 -22.44%
3/5/2011 Clancy Paul J Executive VP and CFO -25,888 $71.15 -35.42%
3/5/2011 Clancy Paul J Executive VP and CFO 28,750 $58.99 64.85%
3/2/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -4,079 $70.10 -23.03%
3/2/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -200 $70.44 -1.92%
3/2/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -3,232 $70.09 -23.71%
3/2/2011 Cox John EVP Pharmaceutical Oper & Tech -2,483 $70.08 -20.02%
3/2/2011 Cox John EVP Pharmaceutical Oper & Tech -1,458 $70.11 -10.52%
3/2/2011 Cox John EVP Pharmaceutical Oper & Tech -100 $70.45 -1.01%
3/2/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -100 $69.02 -0.92%
3/2/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -616 $69.98 -6.04%
3/2/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -100 $70.32 -1.04%
3/2/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -586 $70.17 -5.43%
3/1/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -6,250 $68.62 -26.08%
3/1/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm 6,250 $49.65 35.29%
2/25/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm 9,725 $49.31 48.95%
2/25/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -9,725 $68.20 -32.86%
2/24/2011 ALEXANDER SUSAN H EVP, General Counsel -985 $67.26 -2.35%
2/24/2011 Gagnon Robert E. Chief Acct Officer VP & Contr 1,054 $49.65 9.39%
2/24/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -1,054 $66.99 -8.59%
2/24/2011 ALEXANDER SUSAN H EVP, General Counsel -995 $67.26 -2.43%
2/24/2011 Clancy Paul J Executive VP and CFO -1,098 $67.26 -2.36%
2/24/2011 Clancy Paul J Executive VP and CFO -1,066 $67.26 -2.35%
2/24/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -168 $67.26 -1.52%
2/24/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -995 $67.26 -5.32%
2/24/2011 Cox John EVP Pharmaceutical Oper & Tech -598 $67.26 -3.97%
2/24/2011 Cox John EVP Pharmaceutical Oper & Tech -604 $67.26 -4.18%
2/24/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -1,161 $67.26 -5.84%
2/24/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -167 $67.26 -1.49%
2/23/2011 Clancy Paul J Executive VP and CFO -907 $66.76 -1.90%
2/23/2011 Cox John EVP Pharmaceutical Oper & Tech -129 $66.76 -0.85%
2/23/2011 Cox John EVP Pharmaceutical Oper & Tech -551 $66.76 -3.50%
2/23/2011 Clancy Paul J Executive VP and CFO -212 $66.76 -0.45%
2/23/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -1,295 $66.76 -6.03%
2/23/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -61 $66.76 -0.54%
2/23/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -259 $66.76 -2.24%
2/23/2011 ALEXANDER SUSAN H EVP, General Counsel -809 $66.76 -1.88%
2/23/2011 ALEXANDER SUSAN H EVP, General Counsel -190 $66.76 -0.45%
2/23/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -303 $66.76 -1.50%
2/17/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -732 $67.10 -6.50%
2/17/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -3,194 $67.08 -16.27%
2/17/2011 Cox John EVP Pharmaceutical Oper & Tech -1,843 $67.08 -11.93%
2/12/2011 SCHNEIER CRAIG ERIC EVP, HR, Public Affairs & Comm -1,486 $65.83 -7.04%
2/12/2011 ALEXANDER SUSAN H EVP, General Counsel -1,515 $65.83 -3.67%
2/12/2011 Clancy Paul J Executive VP and CFO -1,686 $65.83 -3.68%
2/12/2011 Cox John EVP Pharmaceutical Oper & Tech -910 $65.83 -5.56%
2/12/2011 Gagnon Robert E. Chief Acct Officer VP & Contr -341 $65.83 -2.94%
2/1/2011 Granata Francesco EVP Global Commercial Operatio -261 $65.49 -8.25%
2/1/2011 Granata Francesco EVP Global Commercial Operatio -1,124 $65.49 -26.22%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (BIIB), click here.
Marketplace
Trading Center